UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1092-1092

2010

Volltextzugriff (PDF)

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1792-1792

2013

Volltextzugriff (PDF)

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3704-3704

2012

Volltextzugriff (PDF)

Abstract 5050: Germline variants in CDKN2A wild-type melanoma prone families

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5050-5050

2024

Volltextzugriff (PDF)

Abstract 7012: Studying mosaic epimutations at scale

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7012-7012

2024

Volltextzugriff (PDF)

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT010-CT010

2017

Volltextzugriff (PDF)

Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors

Human gene therapy, 2002-06, Vol.13 (9), p.1115-1125

2002

Volltextzugriff (PDF)

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Maturitas, 1998-01, Vol.28 (3), p.259-265

1998

Volltextzugriff (PDF)

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Journal of investigative dermatology, 2010-10, Vol.130 (10), p.2514-2516

2010

Volltextzugriff (PDF)

Aminoglutethimide and warfarin: a new important drug interaction

Cancer chemotherapy and pharmacology, 1984, Vol.12 (1), p.10-12

1984

Volltextzugriff (PDF)

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations

Acta oncologica, 2007, Vol.46 (2), p.199-203

2007

Volltextzugriff (PDF)

Antitumor efficacy improved by local delivery of species-specific endostatin

Journal of neurosurgery, 2006, Vol.104 (1), p.118-128

2006

Volltextzugriff (PDF)

APOBEC3A/B deletion polymorphism and endometrial cancer risk

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.6659-6667

2023

Volltextzugriff (PDF)

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Journal of steroid biochemistry and molecular biology, 2008-02, Vol.108 (3), p.196-202

2008

Volltextzugriff (PDF)

Assessing Novel Therapies Based on Late-Stage Efficacy: A Dangerous Concept?

Trends in Cancer, 2021-03, Vol.7 (3), p.181-185

Lønning, Per E

2021

Volltextzugriff (PDF)

Assessment of tumor suppressor promoter methylation in healthy individuals

Clinical epigenetics, 2020-08, Vol.12 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

Oncotarget, 2016-05, Vol.7 (19), p.28637-28646

2016

Volltextzugriff (PDF)

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Nature communications, 2022-01, Vol.13 (1), p.69-69, Article 69

2022

Volltextzugriff (PDF)

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

PloS one, 2012-06, Vol.7 (6), p.e38364

2012

Volltextzugriff (PDF)

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Clinical pharmacokinetics, 2003-01, Vol.42 (7), p.619-631

Lonning, Per E

2003

Volltextzugriff (PDF)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Genome medicine, 2022-08, Vol.14 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

Comment on "Towards a personalized approach to aromatase inhibitor therapy: a digital microfluidic platform for rapid analysis of estradiol in core-needle-biopsies" by S. Abdulwahab, A. H. C. Ng, M. D. Chamberlain, H. Ahmado, L.-A. Behan, H. Gomaa, R. F. Casper and A. R. Wheeler, Lab Chip, 2017, 17, 1594

Lab on a chip, 2017-09, Vol.17 (18), p.3186-3187

Lønning, Per E

2017

Volltextzugriff (PDF)

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer

JAMA oncology, 2022-11, Vol.8 (11), p.1579

2022

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaBreast Neoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(117)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Abstract 5050: Germline variants in CDKN2A wild-type melanoma prone families

Abstract 7012: Studying mosaic epimutations at scale

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Aminoglutethimide and warfarin: a new important drug interaction

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations

Antitumor efficacy improved by local delivery of species-specific endostatin

APOBEC3A/B deletion polymorphism and endometrial cancer risk

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Assessing Novel Therapies Based on Late-Stage Efficacy: A Dangerous Concept?

Assessment of tumor suppressor promoter methylation in healthy individuals

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer

Aktive Filter

Suchergebnisse filtern